Sandbox:lipid: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 189: Line 189:
* Can consider TEE if balancing risk/benefits
* Can consider TEE if balancing risk/benefits
|Degree of calcification and tortuosity of peripheral vasculature
|Degree of calcification and tortuosity of peripheral vasculature
|}
{| class="wikitable"
! colspan="3" |TAVR Imaging Checklist
|-
!Imaging goals
!Recommended Approach
!Additional Details
|-
! colspan="3" |Periprocedure
|-
|Interventional planning
|TAVR [[CT angiography|CTA]]
|Predict optimal fluoroscopy angles for valve
deployment
|-
|Confirmation of annular
sizing
|Preprocedure [[Multidetector computed tomography|MDCT]]
|Consider contrast aortic root injection if
needed
3C TEE to confirm annular size
|-
|Valve placement
|Fluoroscopy under general anesthesia
|[[TEE]] (if using general anesthesia)
|-
|Paravalvular leak
|Direct aortic root angiography
|[[TEE]] (if using general anesthesia)
|-
|Procedural complications
|
* [[TTE]]
* [[Transesophageal echocardiography (TEE)|TEE]] (if using general anesthesia)
 Intracardiac echocardiography (alternative)
|
|-
| colspan="3" |Long-term Postprocedure
|-
|Evaluate valve function
|TTE
|Key elements of echocardiography:
* Maximum aortic velocity
* Mean aortic valve gradient
* [[Aortic valve area]]
* Paravalvular and valvular [[Aortic regurgitation|AR]]
|-
|LV geometry and other
cardiac findings
|TTE:
* [[LVEF]], regional wall motion
* [[Hypertrophy]], diastolic fucntion
* Pulmonary pressure estimate
* Mitral valve ([[Mitral regurgitation|MR]], [[MS]], MAC)
|
|}
|}

Revision as of 14:12, 13 January 2017

 
 
 
 
 
 
 
 
 
 
 
TAVR Imaging Evaluation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TAVR CT
 
 
 
 
 
 
 
 
 
 
 
 
 
ECHO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-gated Angigram of Chest, Abdomen and Pelvic arteries for vascular access selection
 
 
 
 
ECG gated CT of annulus and Aortic root for valve sizing selection
 
 
 
 
 
Left ventricles and other findings
 
 
Confirm severe Aortic Stenosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transfemoral Approach
 
Annular sizing
 
Aortic Root sizing
 
Additional Procedural Planning
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subclavian Approach
 
 
Major/Minor Dimension
 
 
Coronary Ostia height
 
 
Fluoroscopy Angulation
 
 
LVEF and LV dimension
 
 
 
High gradient AS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Apical Approach
 
 
Area
 
 
Aortic Sinus to Commissure dimension
 
 
Bypass Grafts
 
 
Estimated Pulmonary pressure
 
 
 
Low gradient AS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other Approaches
 
 
Circumferences
 
 
Sinotubular Junction
 
 
RV to Chest wall position
 
 
Other valvular abnormalities
 
 
 
 
Reduced EF
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Carotid
 
 
 
 
 
Ascending Aorta dimension
 
 
 
 
 
 
 
 
 
 
 
 
Preserved EF
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct Aortic
 
 
 
 
 
Aortic Calcification
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transvenous
 
 
TAVR Imaging Checklist
Region of Interest Recommended Approach and Key

Measures

Additional Comments
Preprocedure
Aortic valve morphology TTE:
  • Trileaflet, bicuspid or unicuspid
  • Leaflet motion
  • Annular size and shape
  • TEE if can be safely performed, particularly

useful for subaortic membranes

  • Cardiac MRI if echocardiography

nondiagnostic

  • ? ECG-gated thoracic CTA if MRI

contraindicated

Aortic valve function TTE:
  • Maximum aortic velocity
  • Mean aortic valve gradient
  • Aortic valve area
  • Stroke volume index
  • Presence and severity of AR
Additional parameters
  • Dimensionless index
  • AVA by planimetry (echo, CT, MRI)
  • Dobutamine stress echocardiography

for LFLG AS-Reduced EF

  • Aortic valve calcium score if LFLG AS

diagnosis in question

LV Geometry and other

cardiac findings

TTE:
  • LVEF, regional wall motion
  • Hypertrophy, diastolic dysfunction
  • Pulmonary pressure estimate
  • Mitral valve (MR, MS, MAC)
  • Aortic sinus anatomy and size
  • ? Myocardial ischemia and scar: CMR, PET,

DSE, thallium

  • ? CMR imaging for myocardial fibrosis and

scar, identification of cardiomyopathies

Annular sizing
  • TAVR CTA- gated contrast enhanced CT

thorax with multiphasic acquisition

  • Typically reconstructed in systole 30-40%

of the R-R window

  • Major/minor annulus dimension
  • ?Major/minor average
  • ?Annular area
  • ?Circumference/perimeter
Aortic root measurements
  • Gated contrast-enhanced CT thorax with

multiphasic acquisition.

  • Typically reconstructed in diastole 60%–80%.
  • Coronary ostia heights
  • ?Midsinus of Valsalva (sinus to commissure,

sinus to sinus)

  • ?Sinotubular junction
  • ?Ascending aorta (40 cm above valve plane,

widest dimension, at level of PA)

  • ?Aortic root and ascending aorta calcification
Coronary disease and

thoracic anatomy

  • Coronary angiography
  • Nongated thoracic CTA
  • Coronary artery disease severity
  • ?Bypass grafts: number/location
  • ?RV to chest wall distance
  • ?Aorta to chest wall relationship
Noncardiac imaging
  • Carotid ultrasound
  • ?Cerebrovascular MRI
May be considered depending on clinical

history

Vascular Access
Kidney Function Status Recommended Approach Key Parameters
Normal renal function (GFR >60) or

ESRD not expected to recover

  • TAVR CTA
Aorta, great vessel, and abdominal aorta

Dissection; atheroma; stenosis; calcification

Iliac/subclavian/femoral luminal dimensions, calcification, and tortuosity

Borderline renal

function

  • Contrast MRA
  • ?Direct femoral angiography (low contrast)
Institutional dependent protocols

?Luminal dimensions and tortuosity of peripheral vasculature

Acute kidney injury or

ESRD with expected

recovery

  • Noncontrast CT of chest, abdomen, and pelvis
  • ?Noncontrast MRA
  • ?Can consider TEE if balancing risk/benefits
Degree of calcification and tortuosity of peripheral vasculature
TAVR Imaging Checklist
Imaging goals Recommended Approach Additional Details
Periprocedure
Interventional planning TAVR CTA Predict optimal fluoroscopy angles for valve

deployment

Confirmation of annular

sizing

Preprocedure MDCT Consider contrast aortic root injection if

needed

?3C TEE to confirm annular size

Valve placement Fluoroscopy under general anesthesia TEE (if using general anesthesia)
Paravalvular leak Direct aortic root angiography TEE (if using general anesthesia)
Procedural complications
  • ?TEE (if using general anesthesia)

? Intracardiac echocardiography (alternative)

Long-term Postprocedure
Evaluate valve function TTE Key elements of echocardiography:
  • Maximum aortic velocity
  • Mean aortic valve gradient
  • Paravalvular and valvular AR
LV geometry and other

cardiac findings

TTE:
  • LVEF, regional wall motion
  • Pulmonary pressure estimate
  • Mitral valve (MR, MS, MAC)